Fortis Group Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1815183 WESTWOOD, NJ

Position in LLY

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$4,163,221

+$935,749 QoQ

Shares Held

3,471

-1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.83%

of 13F equity value

Holder Rank

#1,851

of 4,601 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $10,238,680 across 11 Drug Manufacturers - General names. LLY ranks #1 (40.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,471	$4,163,221
2	NVO	Novo Nordisk A S	72,916	$3,495,593
3	PFE	Pfizer Inc	62,653	$1,508,683
4	MRK	Merck & Co., Inc.	4,715	$605,877
5	AMGN	Amgen Inc	559	$202,424
6	JNJ	Johnson & Johnson	718	$182,350
7	GILD	Gilead Sciences, Inc.	246	$31,079
8	BMY	Bristol Myers Squibb Co	500	$28,810

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,163,221	3,471	-1.1%	Shares	Sole	2026-07-24
2026-03-31	$3,227,472	3,509	-1.0%	Shares	Sole	2026-05-08
2025-12-31	$3,809,740	3,545	+13.2%	Shares	Sole	2026-02-06
2025-09-30	$2,388,953	3,131	+33.2%	Shares	Sole	2025-11-07
2025-06-30	$1,831,895	2,350	-12.7%	Shares	Sole	2025-08-08
2025-03-31	$2,224,175	2,693	-2.6%	Shares	Sole	2025-05-02
2024-12-31	$2,134,580	2,765	-37.1%	Shares	Sole	2025-01-31
2024-09-30	$3,893,706	4,395	-4.2%	Shares	Sole	2024-10-21
2024-06-30	$4,152,978	4,587	+75.5%	Shares	Sole	2024-07-30
2024-03-31	$2,033,587	2,614	+553.5%	Shares	Sole	2024-04-30
2023-12-31	$233,168	400	+100.0%	Shares	Sole	2024-03-04
2023-09-30	$107,426	200	-93.8%	Shares	Sole	2023-12-01
2020-09-30	$476,772	3,221	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.